NY A01461

Requires nursing homes and health care professionals to obtain informed written consent from residents or their lawful representatives before administering antipsychotic medications

Exempts certain residents from the consent requirement, including those already prescribed antipsychotics before admission, those who consented within the last 12 months, hospice patients, residents in certified behavioral units, and those with Huntington's disease

Mandates specific disclosures for informed consent, including the reason for medication, anticipated benefits, dosage, probability of side effects, alternative treatments, and the right to refuse or revoke consent

Allows antipsychotic medication without consent only in emergencies posing an immediate threat to life, health, or safety, with required documentation and notification to the resident or representative

Takes effect one year after becoming law, with the commissioner authorized to create implementing regulations